DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update
about
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspiratesEpigenetic changes in individuals with arsenicosisEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesQuality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRMDiagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancerCorrelation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence.DNA methylation biomarkers for lung cancer.EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells.Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC).DNA methylation profile and expression of surfactant protein A2 gene in lung cancer.Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.Epigenomics of ovarian cancer and its chemoprevention.Genome Wide Methylome Alterations in Lung Cancer.Analysis of p16 gene mutations and their expression using exhaled breath condensate in non-small-cell lung cancerCombination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.Methylation of the RASSF1A and RARβ genes as a candidate biomarker for lung cancer.microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells.MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases.Radiotherapy diagnostic biomarkers in radioresistant human H460 lung cancer stem-like cells.Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer.Cadmium exposure and the epigenome: Exposure-associated patterns of DNA methylation in leukocytes from mother-baby pairs.Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.DNA methylation as a universal biomarker.Common pathogenic mechanisms and pathways in the development of COPD and lung cancer.European and North American lung cancer screening experience and implications for pulmonary nodule management.DNA methylation testing and marker validation using PCR: diagnostic applications.Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.DNA methylation and cancer diagnosis.Application of capillary electrophoresis for the early diagnosis of cancer.Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1.HMM-Fisher: identifying differential methylation using a hidden Markov model and Fisher's exact test.Characterization of potential driver mutations involved in human breast cancer by computational approaches.The expression of ADAM23 and its correlation with promoter methylation in non-small-cell lung carcinoma.Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation.
P2860
Q21261302-EFBC8740-08EE-4143-83A3-327C36ED98B8Q24617495-0ECAE72E-C2DF-4502-98C6-90F72EA48212Q27023830-32D6804D-9C1B-4DCD-B13C-7CA7E6370B43Q33520069-28A126B9-FEDF-4BAC-9CD7-6F145F33CDC9Q33829495-F01DF349-3DCD-40D3-AD17-8F6A21163F21Q33852594-67C1F475-9B6F-4882-B875-F3EC41B63D59Q33952447-0E02BDCE-61EC-4101-926A-6985ECC1E531Q34129229-74D062B2-1AB6-45E1-8882-DFA1F39BC609Q34238508-99A6D2AF-F4AC-47BB-992C-1F930532CC2DQ34803710-46AF35C4-6B61-4289-AC6F-20EFF4EF63CFQ34826137-43A83BDC-65D7-493F-8270-7CB6A0EB5C66Q35052832-9F2A0A83-74E7-416C-BA41-92ACF53D6573Q35106906-9E2ADEA2-6CBC-41E7-A6D7-397CBF5E2A83Q35357827-B7BC3C10-CD25-4E59-8001-4BF0A5BFC422Q35711392-1BADD3EE-B841-4BE5-A5CA-7C5554C2EB7EQ35873163-88D26AFE-0553-45A0-8554-B4DA35E55A17Q35944426-EE48FF41-9736-480A-84AD-D593F8B1548AQ35964716-14E1434D-9621-437F-BA89-0ED84D1415A9Q36201267-A8E1E383-F964-441A-BA48-CC65C3B07174Q36224164-27A1713E-B808-4C53-92B9-F73016CB25B8Q36230699-70072FF7-F2ED-45FC-8F0C-D6B947DCB239Q36262119-CC73DD2E-BF93-4106-AAB8-3CE187331427Q36642593-FC05D53F-FCF9-41B4-8D80-790D0193A50CQ36844321-AA821A7E-42E6-4315-9095-522F32DD7053Q37306747-71B96504-091D-4A2C-9121-BDCD20D15AF1Q37461935-BFE7362C-DAA5-4617-B6AC-5017D556C003Q37655838-912F2DEC-A63D-4CC4-B9E1-206FE499AC6FQ37711629-6D0067D6-A936-447F-904F-4C4E3EDBB801Q37750858-03B1A9B7-A09B-4F6E-8B8E-D059695CEEACQ37834029-E9EF318E-A223-4C36-A3A3-E3B168CFE438Q37914771-6D8DE54F-9D30-4FE1-BEF6-C50CAB502F3FQ37963517-09ACD110-F701-4CC0-AAEB-0958A904CCC0Q38038406-AFC34653-634D-4091-90D6-078CE343043FQ38123094-443F60E1-71B9-4454-9927-41ADB3A1C38AQ38199367-9E5F871A-503A-43A0-A7EF-314F1572D8BAQ38784231-07AB05F1-BAB7-4DA3-B131-2C425615550DQ38795774-3569FF16-8ABD-42A1-8555-C4477F6BB42CQ39286993-BD8F2FA9-C6B9-40EF-ABCA-D5315EF81328Q39572038-B58D57DC-4687-4C14-AC2E-7E13AC111D8FQ41767411-14C69CF6-0484-42F4-8CAF-C72DA8B704C5
P2860
DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
DNA methylation-based biomarke ...... ll cell lung cancer: an update
@ast
DNA methylation-based biomarke ...... ll cell lung cancer: an update
@en
DNA methylation-based biomarke ...... ll cell lung cancer: an update
@nl
type
label
DNA methylation-based biomarke ...... ll cell lung cancer: an update
@ast
DNA methylation-based biomarke ...... ll cell lung cancer: an update
@en
DNA methylation-based biomarke ...... ll cell lung cancer: an update
@nl
prefLabel
DNA methylation-based biomarke ...... ll cell lung cancer: an update
@ast
DNA methylation-based biomarke ...... ll cell lung cancer: an update
@en
DNA methylation-based biomarke ...... ll cell lung cancer: an update
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
DNA methylation-based biomarke ...... ll cell lung cancer: an update
@en
P2093
Ite A Laird-Offringa
Paul P Anglim
Todd A Alonzo
P2860
P2888
P3181
P356
10.1186/1476-4598-7-81
P407
P5008
P577
2008-10-23T00:00:00Z
P5875
P6179
1015994433